Lead and δ-aminolevulinic acid dehydratase polymorphism: Where does it lead? A meta-analysis

Environmental Health Perspectives

Volumn 115, Issue 1, 2007, Pages 35-41

  Scinicariello, Franco ^a   Murray, H Edward ^a   Moffett, Daphne B ^a   Abadin, Henry G ^a   Sexton, Mary J ^b   Fowler, Bruce A ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b Epidemiologic Consultant   (United States)

Author keywords

ALAD polymorphism; Lead; Meta analysis

Indexed keywords

CREATININE; HEMOGLOBIN; LEAD; NITROGEN; PORPHOBILINOGEN SYNTHASE; PROTOPORPHYRIN ZINC; SUCCIMER; UREA;

ALLELE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BONE; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GENOTYPE; HEMATOPOIESIS; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LEAD POISONING; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIBIA; UREA NITROGEN BLOOD LEVEL; WORKER;

ADULT; ALLELES; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; BONE AND BONES; CHILD; CREATININE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HEMOGLOBINS; HUMANS; LEAD; POLYMORPHISM, GENETIC; PORPHOBILINOGEN SYNTHASE; PROTOPORPHYRINS;

EID: 33845967119     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9448     Document Type: Article

References (62)

1. Alexander BH, Checkoway H, Costa-Mallen P, Faustman EM, Woods JS, Kelsey KT, et al. 1998. Interaction of blood lead and δ-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect 106:213-216.
2. Astrin KH, Bishop DF, Wetmur JG, Kaul B, Davidow B, Desnick RJ. 1987. δ-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann NY Acad Sci 514:23-29.
3. ATSDR. 1999. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
4. Baldwin DR, Marshall WJ. 1999. Heavy metal poisoning and its laboratory investigation. Ann Clin Biochem. 36:267-300.
5. Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S. 1981. δ-Aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 45:223-229.
6. Begg BC, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
7. Bellinger D, Hu H, Titlebaum L, Needleman HL. 1994. Attentional correlates of dentin and bone lead levels in adolescent. Arch Environ Health 49:98-105.
8. Bergdahl IA, Gerhardsson L, Schutz A, Desnick RJ, Wetmur JG, Skerfving S. 1997a. δ-Aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 52:91-96.
9. Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S, et al. 1997b. Lead binding to δ-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81:153-158.
10. Bogden JD, Kemp FW, Han S, Murphy M, Fraiman M, Czerniach D, et al. 1995. Dietary calcium and lead interact to modify maternal blood pressure, erythropoiesis, and fetal and neonatal growth in rats during pregnancy and lactation. J Nutr 125:990-1002.
11. Brennan MJ, Cantrill RC. 1979. Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature 280:514-515.
12. Chisolm JJ Jr, Thomas DJ, Hamill TG. 1985. Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children. Clin Chem 31:601-605.
13. Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, et al. 2002. Evidence for association of a common variant of the endothelialnitric oxide synthase gene (Glu298-Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87:525-528.
14. Dusso AS, Brown AJ, Slatopolsky E. 2005. Vitamin D. Am J Physiol Renal Physiol 289:F8-F28.
15. Duydu Y, Suzen HS. 2003. Influence of δ-aminolevulinic acid dehydratase (ALAD) polymorphism on the frequency of sister chromatid exchange (SCE) and the number of high-frequency cells (HFCs) in lymphocytes from lead-exposed workers. Mutat Res. 540:79-88.
16. Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple graphic test. BMJ 315:629-634.
17. Fleming DE, Chettle DR, Wetmur JG, Desnick RJ, Robin JP, Boulay D, et al. 1998. Effect of the δ-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res 77:49-61.
18. Fullmer CS. 1990. Intestinal lead and calcium absorption: effect of 1,25-dihydroxycholecalciferol and lead status. Proc Soc Exp Biol Med 194:258-264.
19. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
20. Hsieh LL, Liou SH, Chen YH, Tsai LC, Yang T, Wu TN. 2000. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med 42:151-155.
21. Hu H, Wu MT, Cheng Y, Sparrow D, Weiss S, Kelsey K. 2001. The δ-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect 109:827-832.
22. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopouloa-Ioannidis DG. 2003. Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571.
23. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. 2001. δ-Aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 154:1-13.
24. Kim HS, Lee SS, Lee GS, Hwangbo Y, Ahn KD, Lee BK. 2004. The protective effect of δ-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters. Environ Health Perspect 112:538-541.
25. Kopp SJ, Barron JT, Tow JP. 1988. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect 89:91-99.
26. Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, et al. 2001. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 109:383-389.
27. Lee SS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. 2001. Associations of lead biomarkers and δ-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers. Scand J Work Environ Health 27:402-411.
28. Mahaffey KR, Gartside PS, Glueck CJ. 1986. Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976-1980. Pediatrics 78:257-262.
29. Marcus AH. 1985a. Multicompartment kinetic models for lead: Part I. Bone kinetics and variable absorption in humans without excessive lead exposures. Environ Res 36:441-458.
30. Marcus AH. 1985b. Multicompartment kinetic models for lead: Part II. Linear kinetics and variable absorption in humans without excessive lead exposures. Environ Res 36:459-472.
31. McAllister RG Jr, Michelakis AM, Sandstead HH. 1971. Plasma renin activity in chronic plumbism. Arch Int Med 127:919-923.
32. National Library of Medicine. Medline Database. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed [accessed 31 December 2005].
33. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. 2002. An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 16:123-131.
34. Onalaja AO, Claudio L. 2000. Genetic susceptibility to lead poisoning. Environ Health Perspect 108:S23-S28.
35. Perez-Bravo F, Ruz M, Moran-Jimenez MJ, Olivares M, Rebolledo A, Codoceo J, et al. 2004. Association between aminolevulinate dehydrase genotypes and blood lead levels in children from a lead-contaminated area in Antofagasta, Chile. Arch Environ Contam Toxicol 47:276-280.
36. Pirkle JL, Schwartz J, Lamdis JR, Harlan WR. 1985. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol 121:246-258.
37. Ponka P. 1997. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89:1-25.
38. Rabinowitz MB, Wetherill GM, Kopple JD. 1976. Kinetics analysis of lead metabolism in healthy humans. J Clin Invest 58:260-270.
39. Roels HA, Boeckx M, Ceulemans E, Lauwerys RR. 1990. Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour. Br J Ind Med 47:331-337.
40. Sakai T, Morita Y, Araki T, Kano M, Yoshida T. 2000. Relationship between δ-aminolevulinic acid dehydratase genotypes and heme precursors in lead workers. Am J Ind Med 38:355-360.
41. Sandstead HH, Michelakis AM, Temple TE. 1970. Lead intoxication. Its effect on the renin-aldosterone response to sodium deprivation. Arch Environ Health 20:356-363.
42. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, Kelsey K. 1995. Associations of δ-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142:738-745.
43. Schwartz BS, Lee BK, Stewart W, Ahn KD, Kelsey K, Bressler J. 1997a. Associations of subtypes of hemoglobin with δ-aminolevulinic acid dehydratase genotype and dimercaptosuccinic acid-chelatable lead levels. Arch Environ Health 52:97-103.
44. Schwartz BS, Lee BK, Stewart W, Sithisarankul P, Strickland PT, Ahn KD, et al. 1997b. δ-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 54:241-246.
45. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. 2000. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 108:949-954.
46. Shen XM, Wu SH, Yan CH, Zhao W, Ao LM, Zhang YW, et al. 2001. δ-Aminolevulinate dehydratase polymorphism and blood lead levels in Chinese children. Environ Res 85:185-190.
47. Sithisarankul P, Schwartz BS, Lee BK, Kelsey KT, Strickland PT. 1997. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med 32:15-20.
48. Smith CM, Wang X, Hu H, Kelsey KT. 1995. A polymorphism in the δ-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253.
49. Sofowora G, Dishy V, Xie HG, Imamura H, Nishimi Y, Morales CR, et al. 2001. In vivo effect of Glu298Asp endothelial nitric oxide synthase polymorphism. Pharmacogenetics 11:809-814.
50. Suzen HS, Duydu Y, Aydin A, Isimer A, Vural N. 2003. Influence of the δ-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers. Am J Ind Med 43:165-171.
51. Theppeang K, Schwartz BS, Lee BK, Lustberg ME, Silbergeld EK, Kelsey KT, et al. 2004. Associations of patella lead with polymorphisms in the vitamin D receptor, δ-aminolevulinic acid dehydratase and endothelial nitric oxide synthase genes. J Occup Environ Med 46:528-537.
52. Thomson Scientific. Web of Science. Available: http://scientific.thomson.com/products/wos/ [accessed 31 December 2005].
53. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. 2006. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 163:300-309.
54. Vaziri ND, Liang K, Ding Y. 1999. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56:1492-1498.
55. Vaziri ND, Ding Y. 2001. Effect of lead on nitric oxide synthase expression in coronary endothelial cells. Hypertension 37:223-226.
56. Warren MJ, Cooper JB, Wood SP, Shoolingin-Jordan PM. 1998. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci 23:217-21.
57. Weaver VM, Schwartz BS, Ahn KD, Stewart WF, Kelsey KT, Todd AC, et al. 2003. Associations of renal function with polymorphisms in the δ-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect 111:1613-1619.
58. Wetmur JG, Lehnert G, Desnick RJ. 1991a. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56:109-119.
59. Wetmur JG, Kaya AH, Plewinzka M, Desnick RJ. 1991b. Molecular characterization the human δ-aminolevulinate dehydratase 2 (ALAD 2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 49:757-63.
60. Wu FY, Chang PW, Wu CC, Lai JS, Kuo HW. 2004. Lack of association of δ-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers. Int Arch Occup Environ Health 77:395-400.
61. Wu MT, Kelsey K, Schwartz J, Sparrow D, Weiss S, Hu H. 2003. A δ-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environ Health Perspect 111:335-341.
62. Ziemsen B, Angerer J, Lehnert G, Benkmann HG, Goedde HW. 1986. Polymorphism of δ-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 58:245-247.